more women with breast cancer treated with a bisphosphonate

September 1998

You'll see more women with breast cancer treated with a bisphosphonate...Aredia (pamidronate), Fosamax (alendronate), etc.

Surprising new research suggests these drugs reduce metastasis to the bone and other organs...and prolong survival.

These drugs seem to inhibit release of growth factors in bone that stimulate tumor growth. Some bisphosphonates also seem to directly promote cell death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote